K Breddin

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Semiquantitative assessment of lower limb atherosclerosis from routine angiographic images

A Bollinger, K Breddin, H Hess et al. · Atherosclerosis · 1981 · 123 citations

Vascular Image, Medical Imaging, Cardiovascular Disease +11

Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon

K Breddin, D Loew, Klaus Lechner et al. · Pathophysiology of Haemostasis and Thrombosis · 1980 · 108 citations

Total Mortality, Cardiovascular Pharmacology, Pharmacotherapy +20

The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.

K Breddin, D. Loew, Karl–Heinz Lechner et al. · PubMed · 1980 · 99 citations

Total Mortality, Pharmacotherapy, Preventive Cardiology +18

Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo

K Breddin, D Loew, Klaus Lechner et al. · Thrombosis and Haemostasis · 1979 · 83 citations

Thrombosis, Myocardial Infarction Comparison, Acetylsalicylic Acid +11